PP
BIOR

Paloma Partners’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Paloma Partners’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-72
Closed -$64K – 2092
2021
Q2 		$64K Sell
72
-53
-42% -$40.5K ﹤0.01% 1684
2021
Q1 		$148K Buy
125
+15
+14% +$20.7K ﹤0.01% 1854
2020
Q4 		$146K Buy
+110
New +$161K ﹤0.01% 1454

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Paloma Partners's BIOR Position: Q3 2021 in Review

Paloma Partners sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q3 2021, closing a stake of 72 shares — an estimated $64K sold.

Paloma Partners first reported a position in BIOR in Q4 2020 and held it in 3 quarters. The position peaked at $148K in Q1 2021. 35 funds tracked by Wall St. Rank hold BIOR as of Q3 2021.

  • Paloma Partners reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Paloma Partners sold 72 Biora Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $64K.
  • Paloma Partners first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Paloma Partners's Biora Therapeutics, Inc. Common Stock position peaked at $148K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Paloma Partners's 13F filing for Q3 2021, filed 15 Nov 2021.